Bleakley Financial Group, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Bleakley Financial Group, LLC

  • $3.28 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
SELL
$1.06 - $1.67 $2,253 - $3,550
-2,126 Reduced 15.99%
11,172 $13 Million
Q4 2023

Jan 25, 2024
BUY
$1.26 - $1.79 $3,751 - $5,328
2,977 Added 28.84%
13,298 $22.5 Million
Q3 2023

Nov 14, 2023
SELL
$1.61 - $2.54 $9,845 - $15,532
-6,115 Reduced 37.2%
10,321 $18.7 Million
Q2 2023

Aug 14, 2023
BUY
$1.14 - $1.95 $18,737 - $32,050
16,436 New
16,436 $30.6 Million
Q4 2022

Feb 07, 2023
BUY
$1.63 - $3.52 $23,247 - $50,202
14,262 New
14,262 $24.1 Million

Others Institutions Holding DNA

# of Institutions
41
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.6B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email